We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Test Being Developed for Hitherto Unrecognized Endurance Enhancers

By LabMedica International staff writers
Posted on 15 Jan 2009
A new test will allow sports officials to screen for emerging performance-enhancing drugs.

The test detects a core chemical structure belonging to a class of compounds called benzothiazepines. More...
These compounds stabilize protein channels that would otherwise leak calcium from muscle cells during strenuous exercise. Calcium is needed for muscle contraction and the leaking effect weakens the contractions and causes muscle fatigue.

Dr. Mario Thevis, director of the center for preventive doping research at the German Sport University (Cologne, Germany) and colleagues characterized the compounds according to their weight and molecular structure. This provided a molecular "fingerprint" by which to identify the compounds. Using high-resolution mass spectrometry, JTV-519 and S-107, benzothiazepines currently in development for the treatment of heart abnormalities, were detected in spiked urine at concentrations as low as 0.1 ng/mL.

The Beijing Olympics 2008 (China) were remarkably drug free; only six athletes were caught during the games and three more cases identified after the games closed. It is possible that some athletes were using drugs that could not be detected by available tests. Perhaps they used compounds that had not yet been tested in humans, but were known to have performance-enhancing properties in mice.

"We used the common approaches that are employed for detecting anabolic agents. Our work showed that we could identify the right compounds and that we have a sensitive test," said Dr. Thevis.

Related Links:
German Sport University




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Repetitive Pipette
VWR® Stepper Pro
New
Total Laboratory Automation Solution
SATLARS Mini T8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.